PeerVoice Internal Medicine Video artwork

Lindsey Roeker, MD - Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimilar Agents

PeerVoice Internal Medicine Video

English - May 21, 2024 23:00 - 20 minutes
Science medical education peervoice internal medicine dermatology nephrology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Christian Récher, MD, PhD - Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Optimising Our First-Line Approaches With Current and Novel Therapeutics
Next Episode: Angela Kay Fitch, MD, FACP, MFOMA - Unpacking Impressions and Perceptions of Novel Treatments for Obesity: How Would You Respond to These Questions in Primary Care?

Lindsey Roeker, MD - Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimilar Agents